ストックスクリーナーアプリを入手
117.73
0.07%
0.08
アフターアワーズ：
117.73
Abbott Laboratories (ABT) 最新ニュース
Baby Formula Trial, HHS Win At 5th Circ. And Trans Care Suits - Law360
Abbott touts long-term efficacy for dissolvable Esprit BTK stent - Yahoo Finance
Abbott Laboratories (NYSE:ABT) Shares Up 0% Following Analyst Upgrade - MarketBeat
Analyst Ratings For Abbott Laboratories - Benzinga
Abbott Laboratories (NYSE:ABT) Stock Price Expected to Rise, Barclays Analyst Says - MarketBeat
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Abbott Laboratories Insiders Sell US$3.0m Of Stock, Possibly Signalling Caution - Yahoo Finance
Gulf International Bank UK Ltd Sells 5,751 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Missouri Judge Bars Kirkland Partner from Abbott Infant Formula Trial - Lawyer Monthly Magazine
Abbott price target raised to $149 from $143 at Barclays - Yahoo Finance
Prediabetes Market to hit USD 360.6 million by 2032, says Global Market Insights Inc. - GlobeNewswire Inc.
Germany Home Healthcare Market Forecast Report 2024-2032 - GlobeNewswire Inc.
Will glucose monitors become the next wellness accessory? - Sunbury Daily Item
Is Abbott Laboratories (ABT) the Best Pharma Stock to Buy Right Now? - Insider Monkey
Abbott Laboratories stock outperforms competitors despite losses on the day - MarketWatch
Abbott Laboratories (NYSE:ABT) Trading Up 0.1%Here's Why - MarketBeat
Abbott Labs Stock Price Target Hike – Closing In on 52 Wk High - AskTraders
Abbott Labs stock target increased, overweight on NEC case outcome - Investing.com
Jury sides with Abbott Laboratories in ongoing fight over preterm infant formulas - MSN
Abbott Laboratories (NYSE:ABT) Shares Sold by Pure Financial Advisors LLC - MarketBeat
Cancer Molecular Diagnostics Market Expected to Huge Growth - openPR
Hundreds of lawsuits allege Abbott Laboratories’ formula for premature infants made babies sick. But is the formula to blame? - Chicago Tribune
Fort Pitt Capital Group LLC Has $90.98 Million Stock Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Stephens Inc. AR Sells 4,369 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Jim Cramer's hopeful on Abbott Labs after court case win - MSN
Abbot Avoids 'Eye-Popping' Baby Formula Verdict, And Surges - Investor's Business Daily
Abbott Laboratories stock outperforms competitors on strong trading day - MarketWatch
Abbott, Reckitt found not liable in baby formula case. Stocks rise. - Yahoo Finance
Abbott Laboratories (NYSE:ABT) Trading 4.8% HigherTime to Buy? - MarketBeat
Abbott Laboratories Target of Unusually Large Options Trading (NYSE:ABT) - MarketBeat
Defense Verdict Returned in NEC Lawsuit Against Abbott, Mead Johnson in Missouri State Court - AboutLawsuits.com
Abbott Laboratories (ABT) Stock Price, Trades & News - GuruFocus.com
Abbott shares rise after securing first win in premature infant formula trial - MSN
Abbott Laboratories Up Over 5%, On Track for Largest Percent Increase Since April 2023 — Data Talk - Morningstar
Abbott Laboratories (NYSE:ABT) Shares Gap UpWhat's Next? - MarketBeat
Abbott, Reckitt Stocks Gain as Baby Formula Makers Score Rare Legal Win - Investopedia
Abbott, Reckitt Score First Victory in Baby Formula Trial - Claims Journal
Jim Cramer: Abbott stock is ‘dirt cheap’ after a surprising legal win validates our conviction - CNBC
Reckitt and Abbott Shares Rally on Baby Formula Lawsuit Win - TipRanks
Abbott shares rise following baby formula verdict - MSN
Reckitt, Abbott surge after winning an NEC case - MSN
Reckitt’s Mead Johnson, Abbott cleared by US court in infant-formula case - just-food.com
Abbott Labs' Stock Gains After Favorable Formula Lawsuit Verdict - Finimize
Abbott Shares Rise After Securing First Win in Premature Infant Formula Trial - U.S News & World Report Money
Returns At Abbott Laboratories (NYSE:ABT) Are On The Way Up - Yahoo Finance
Abbott Labs and Reckitt Benckiser shares surge on court’s baby formula ruling - MarketWatch
Abbott climbs on being cleared of liability in latest preterm formula case - XM
Reckitt, Abbott Shares Rise After Baby-Formula Lawsuit Win - The Wall Street Journal
JFS Wealth Advisors LLC Purchases 8,125 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Reckitt, Abbott surge after winning an NEC case By Investing.com - Investing.com Canada
Abbott, Reckitt Stocks Rise on Baby-Formula Lawsuit Win - The Wall Street Journal
Reckitt Surges Most in 24 Years After Baby Formula Trial Win - BNN Bloomberg
Reckitt, Abbott cleared of liability in latest baby formula trial - ShareCast
Dividend Kings In Focus: Abbott Laboratories - Sure Dividend
Decoding Abbott Laboratories (ABT): A Strategic SWOT Insight - Yahoo Finance
Stocks to Watch: Intel, Amazon.com, Abbott Laboratories, MasTec - MarketWatch
0.81%
大文字化:
|
ボリューム (24 時間):